Remedivasher: What You Need to Know About Covid-19 Drug Remedivasher

Remedivasher: What You Need to Know About Covid-19 Drug Remedivasher

New Delhi: The US Food and Drug Administration on Thursday approved code-19 as the first drug to treat hospitalized patients.
Here’s what you need to know about memory:
In a major study led by the US National Institutes of Health, the drug, called Vaclary by California-based Glade Sciences Inc., reduced the average from five days to 15 days. Is.
Vacillary is approved for people who are at least 12 years old and weigh at least 88 pounds (40 kg) who have been hospitalized for a corona virus infection. For patients under the age of 12, the FDA will still allow the use of drugs in certain cases under certain emergency permits.
Europe, India and other countries like Canada have also given temporary approval for the use of memories.
President Donald Trump, who tested positive for the corona virus in early October, was treated with Remedieshire at a military hospital outside Washington, among other drugs.
The drug was first developed to treat Ebola, a viral hemorrhagic fever.
How it works
RemediesDavire, which is administered by injection, was one of the first drugs to make a relatively promising time in recovering some coronavirus patients.
The virus works by blocking any substance used by the virus to make its own copies. Patients need to have some kidney and liver examination before starting it to make sure it is safe for them and can monitor for any possible side effects.
Price
Gilead receives عام 2,340 for a general course of treatment for people enrolled in public health programs in the United States and other developed countries, and $ 3,120 for privately insured patients.
Zydos has priced it at Rs 2,800 (.4 37.44) per 100mg bottle in India. It is being sold under the name Remedac in public and private hospitals treating patients with COMD-19.
About what the WHO misses
However, the World Health Organization (WHO) said last week that its global trial of coveted therapies had shown that there was no specific remedy for remediation in patients’ length of hospital stay or life expectancy. Not affected. This study was not reviewed by external experts.
Gilead has questioned the possibility of bias in the WHO study.
Rejecting WHO claims, doctors in India insist on remedial treatment
Rejecting the World Health Organization’s (WHO) claim of remediation, the core group of Core Cove 19 at Sui Man Singh Medical College in Jaipur said it had been effective in preventing deaths.
“Remedies are a very effective medicine available to coward patients and help prevent deaths. “We do not fully agree with the World Health Organization’s claim to memory,” said Dr. Sudhir Bhandari, principal and controller of SMS Medical College, and head of the core group of therapies.
(With agency inputs)

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *